Schedule 13G ownership disclosure
PROTEON THERAPEUTICS INC
Security class unavailable · CUSIP: 74371L109
Event date: 2014-10-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,250,000
- Percent of class
- 8.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-064444
- Form type
- SC 13G
- Filer
- Protara Therapeutics, Inc.
- CIK
- CIK 1359931
- Filed
- Oct 31, 2014
- Reporting period
- Oct 22, 2014
- Description
- Schedule 13G beneficial ownership